More than 7 million Americans live with Alzheimer's. Dr. Jon LaPook discusses new tools and treatments that could change the course of the disease.
Breakdown
- A new drug, Lekembe, has been approved to treat early-stage Alzheimer's. 47s
- Lekembe removes amyloid plaques in the brain, slowing mental decline by about 30% over 18 months. 56s
- The drug carries FDA black box warnings for risks of brain swelling and bleeding, requiring regular MRI monitoring. 1m 17s
- Carla Minor has received seven infusions and remains independent, but it is too soon to assess the treatment's effectiveness. 1m 34s
- The new treatment offers hope for Alzheimer's patients and families despite potential risks. 1m 56s